A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Solid Tumor Cancer · Non Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hunan Provincial Cancer Hospital, Hunan, Changsha, China
Contact: Study coordinator (Lin Wu, Dr) · wulin-calf@vip.163.com · 0731-89766300
Contact: Principal Investigator (Lin Wu, Dr)
Shandong Cancer Hospital, Jinan, Shangdong, China
Second Affiliated Hospital of Army Medical University, PLA, Chongqing, China
Contact: Study coordinator (Bo Zhu, Dr)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Cancer · Tumor, Solid · Malignant Neoplasm

Abroad (travel likely)RecruitingPHASE1, PHASE2

Austin, United States · Irving, United States

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Advanced Solid Tumor · Cutaneous Tumor · Subcutaneous Tumor

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States · Boston, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · La Jolla, United States